A fictional period tracking app called “RedWave” has emerged as part of a creative campaign to highlight reproductive rights concerns ahead of the 2024 election. The initiative comes from Creatives for Harris, a group of creative professionals organizing with their skills and time to support the Harris-Walz ticket in 2024. The satirical campaign presents the app as one “designed by men, for…
Extend Fertility has released the results of an 8-year comprehensive study on egg freezing success rates, providing new insights into the effectiveness of fertility preservation. The findings, presented at the American Society of Reproductive Medicine Conference in Denver, demonstrate significant success rates and changing trends in egg freezing demographics. The study, which followed 3,100 unique patients through 4,600 egg freezing cycles between…
Bayer has announced a partnership with deep-tech startup Impli to advance the development of what could become the first real-time hormone monitoring device. The collaboration aims to make fertility treatment more accessible, safer, and more successful while exploring broader applications of hormone monitoring technology. The partnership follows Impli’s win at a Bayer-sponsored innovation challenge during the HLTH Europe conference earlier this year.…
In what could mark a significant shift in fertility treatment, Celmatix has announced the nomination of its first lead compound in its oral Follicle Stimulating Hormone receptor (FSHR) agonist drug development program. The breakthrough, announced during the American Society for Reproductive Medicine (ASRM) annual meeting in Denver, could potentially transform fertility treatments by replacing traditional hormone injections with oral medications. The development…
The Biden-Harris Administration has announced a proposed rule that would mark the most significant expansion of contraception coverage under the Affordable Care Act since 2012. The proposal aims to increase coverage of contraception without cost sharing for 52 million women of reproductive age with private health insurance. The proposed rule introduces three key changes to expand contraception access: First, it would enable…
Legacy, a leading sperm testing and freezing company in the U.S., and Posterity Health, a virtual-first soltuion for male reproductive health, have announced a partnership to provide end-to-end male fertility and hormone health care. The collaboration creates a hybrid care model combining Legacy’s at-home testing capabilities with Posterity Health’s specialized treatment services. The program offers baseline semen analysis through Legacy to understand…
Evvy, a female-founded biotech startup, has published peer-reviewed validation for its Vaginal Health Test and presented new findings at multiple clinical conferences. The validation study, published in the Diagnostics journal, analyzed over 7,000 vaginal microbiome samples using Evvy’s CLIA, CAP, and CLEP-certified Vaginal Health Test. The results demonstrated a sensitivity of 93.1 percent and specificity of 90 percent across more than 700…
Astec, a global manufacturer of medical equipment for assisted reproduction, has acquired Life Whisperer, the AI fertility product developed by Presagen. Life Whisperer is a non-invasive and rapid embryo and egg (oocyte) assessment tool designed to improve pregnancy outcomes for IVF patients. Life Whisperer consists of three AI algorithms. The first, Life Whisperer Viability, assesses images of embryos to determine the likelihood…
